Clinical Trial: Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Randomized Controlled Trial Comparing Outcomes in Patients Treated With Merocel Packing or Thrombin-JMI for Anterior Epistaxis

Brief Summary: Epistaxis is a common problem among people of all ages and backgrounds. However, occasionally epistaxis can be severe enough to require emergency room admission. Among the treatment options for epistaxis, nasal packing is the most common approach. This approach requires a return visit to the clinic for removal of the packing. Additionally, there is a great deal of pain during the insertion and removal of this packing. This study aims to justify the further investigation of thrombin as a potential treatment approach for these patients. Thrombin could provide a treatment approach that reduces pain and eliminates the need for a return visit to the clinic.

Detailed Summary:
Sponsor: University of Kansas Medical Center

Current Primary Outcome: Cessation of Epistaxis [ Time Frame: baseline, day 4-6 ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Kansas Medical Center

Dates:
Date Received: December 23, 2008
Date Started: December 2008
Date Completion:
Last Updated: December 10, 2015
Last Verified: December 2015